SLC5A2 and type 2 diabetes mellitus: This study of young persons with T2D and early kidney injury demonstrates that treatment with SGLT2i was associated with significant transcriptional changes across virtually all tubular segments in the kidney, despite localization of SGLT2 expression to PT cells.